Pfizer

Pfizer

Pfizer

Breakthroughs that change patients'​ lives
Type
B2b
Follow us
Alexa global traffic share
Twitter followers
Team Size
1–10
Employees
Ars Technica

Older adults got higher omicron protection by switching from Pfizer to Moderna

SiliconRepublic

Pfizer snaps up migraine drugmaker Biohaven for $11.6bn

Pulse 2.0 , MedCity News

Why Pfizer (PFE) Is Buying Biohaven Pharmaceutical (BHVN) For $11.6 Billion In Cash

Business Plus

Pfizer profits breeze past Wall Street expectations

MedCity News

FDA lifts Pfizer gene therapy clinical hold, but trial adds new safety measures

MedCity News

Biohaven migraine drug partnered with Pfizer lands twin European approvals

CNET

Pfizer Recalls Some Batches of Its Blood Pressure Medication

SiliconBeat

Covid-19 booster raises antibody levels against Omicron for children ages 5 through 11, Pfizer and BioNTech say

Pulse 2.0

Pfizer (PFE) Stock: $75 Price Target And Overweight Rating

Pulse 2.0

Pfizer (PFE) Stock: $55 Price Target And Equal-Weight Rating

Pulse 2.0

Pfizer (PFE) Stock: $57 Price Target From Citi

Pulse 2.0 , MedCity News

Why Pfizer (PFE) Is Buying ReViral For Up To $525 Million

Pulse 2.0

Pfizer (PFE) Stock: Why The Price Increased Today

Ars Technica

Pfizer, Moderna vaccines spur slightly different antibodies, study finds

MedCity News

Data and regulatory roundup: Pfizer’s feat, an ADHD miss, Eli Lilly’s CRL & more

MedCity News

AN2 Therapeutics’ IPO raises $69M to take antibiotic from Pfizer into pivotal test

MedCity News

Pfizer CEO pushes annual Covid shot, but experts disagree

MedCity News

Alnylam sues Moderna & Pfizer, claiming Covid-19 vaccines infringe lipid patent

CNET

Pfizer Asks FDA to Authorize Extra COVID Booster for Older Adults

Tech Times

Pfizer Pushes for 4th COVID-19 Vaccine Dose: Is This for Life After the Pandemic?